Insider Trades184 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | Sell | BSX | Jonathan Monson | EVP and CFO | 1,010 | $43.06 | $65.4B | -59.79% | +4.34% | $43.5K | -2.18% | — | Sell Now |
| May 28, 2026 | Sell | BSX | Michael F Mahoney | Chairman, President & CEO | 386,755 | $49.11 | $65.4B | -59.79% | +4.34% | $19.0M | -100.00% | — | Sell Now |
| May 2, 2026 | Sell | BSX | Padraig Andrew O'Connor | EVP, Global Operations | 872 | $56.50 | $65.4B | -59.79% | +4.34% | $49.3K | -11.04% | — | Sell Now |
| May 2, 2026 | Sell | BSX | Arthur C Butcher | EVP& Grp Pres, MedSurg & APAC | 1,007 | $56.50 | $65.4B | -59.79% | +4.34% | $56.9K | -1.74% | — | Sell Now |
| Mar 1, 2026 | Sell | BSX | Emily Woodworth | SVP, Global Controller and CAO | 372 | $76.85 | $65.4B | -59.79% | +4.34% | $28.6K | -7.58% | — | Sell Now |
| Feb 13, 2026 | Sell | BSX | Miriam O'Sullivan | SVP, Chief HR Officer | 820 | $74.73 | $65.4B | -59.79% | +4.34% | $61.3K | -1.53% | — | Sell Now |
| Feb 13, 2026 | Sell | BSX | Padraig Andrew O'Connor | EVP, Global Operations | 987 | $74.73 | $65.4B | -59.79% | +4.34% | $73.8K | -4.91% | — | Sell Now |
| Feb 13, 2026 | Sell | BSX | Emily Woodworth | SVP, Global Controller and CAO | 1,269 | $74.73 | $65.4B | -59.79% | +4.34% | $94.8K | -10.34% | — | Sell Now |
| Feb 13, 2026 | Sell | BSX | Jonathan Monson | EVP and CFO | 1,698 | $74.73 | $65.4B | -59.79% | +4.34% | $126.9K | -1.41% | — | Sell Now |
| Feb 13, 2026 | Sell | BSX | Vance R Brown | EVP, GC and Corp. Secretary | 14,577 | $74.73 | $65.4B | -59.79% | +4.34% | $1.1M | -8.11% | — | Sell Now |
| Feb 13, 2026 | Sell | BSX | Arthur C Butcher | EVP& Grp Pres, MedSurg & APAC | 27,914 | $74.73 | $65.4B | -59.79% | +4.34% | $2.1M | -13.89% | — | Sell Now |
| Feb 13, 2026 | Sell | BSX | Joseph Michael Fitzgerald | EVP & Group Pres, Cardiology | 36,900 | $74.73 | $65.4B | -59.79% | +4.34% | $2.8M | -5.39% | — | Sell Now |
| Feb 13, 2026 | Sell | BSX | Michael F Mahoney | Chairman, President & CEO | 147,954 | $74.73 | $65.4B | -59.79% | +4.34% | $11.1M | -3.02% | — | Sell Now |
| Feb 12, 2026 | Sell | BSX | Emily Woodworth | SVP, Global Controller and CAO | 242 | $74.12 | $65.4B | -59.79% | +4.34% | $17.9K | -1.75% | — | Sell Now |
| Feb 12, 2026 | Sell | BSX | Miriam O'Sullivan | SVP, Chief HR Officer | 338 | $74.12 | $65.4B | -59.79% | +4.34% | $25.1K | -1.01% | — | Sell Now |
| Feb 12, 2026 | Sell | BSX | Padraig Andrew O'Connor | EVP, Global Operations | 457 | $74.12 | $65.4B | -59.79% | +4.34% | $33.9K | -1.90% | — | Sell Now |
| Feb 12, 2026 | Sell | BSX | Vance R Brown | EVP, GC and Corp. Secretary | 488 | $74.12 | $65.4B | -59.79% | +4.34% | $36.2K | -0.78% | — | Sell Now |
| Feb 12, 2026 | Sell | BSX | Jonathan Monson | EVP and CFO | 573 | $74.12 | $65.4B | -59.79% | +4.34% | $42.5K | -0.73% | — | Sell Now |
| Feb 12, 2026 | Sell | BSX | Arthur C Butcher | EVP& Grp Pres, MedSurg & APAC | 1,302 | $74.12 | $65.4B | -59.79% | +4.34% | $96.5K | -1.57% | — | Sell Now |
| Feb 12, 2026 | Sell | BSX | Joseph Michael Fitzgerald | EVP & Group Pres, Cardiology | 1,612 | $74.12 | $65.4B | -59.79% | +4.34% | $119.5K | -0.67% | — | Sell Now |
| Feb 12, 2026 | Sell | BSX | Michael F Mahoney | Chairman, President & CEO | 6,626 | $74.12 | $65.4B | -59.79% | +4.34% | $491.1K | -0.40% | — | Sell Now |
| Feb 2, 2026 | Sell | BSX | Michael F Mahoney | Chairman, President & CEO | 256,655 | $68.23 | $65.4B | -59.79% | +4.34% | $17.5M | -1.01% | 10b5-1 | Sell Now |
| Dec 1, 2025 | Sell | BSX | Arthur C Butcher | EVP& Grp Pres, MedSurg & APAC | 34,626 | $63.18 | $65.4B | -59.79% | +4.34% | $2.2M | +0.00% | 10b5-1 | Sell Now |
| Nov 28, 2025 | Sell | BSX | Miriam O'Sullivan | SVP, Chief HR Officer | 260 | $101.58 | $65.4B | -59.79% | +4.34% | $26.4K | -1.73% | — | Sell Now |
| Nov 12, 2025 | Sell | BSX | Joseph Michael Fitzgerald | EVP & Group Pres, Cardiology | 10,300 | $104.13 | $65.4B | -59.79% | +4.34% | $1.1M | -2.89% | — | Sell Now |
| Nov 3, 2025 | Sell | BSX | Joseph Michael Fitzgerald | EVP & Group Pres, Cardiology | 100,000 | $62.81 | $65.4B | -59.79% | +4.34% | $6.3M | +0.00% | 10b5-1 | Sell Now |
| Oct 29, 2025 | Buy | BSX | Michael F Mahoney | Chairman, President & CEO | 312,185 | $100.30 | $65.4B | -59.79% | +4.34% | $31.3M | +1.43% | — | Sell Now |
| Oct 1, 2025 | Sell | BSX | Joseph Michael Fitzgerald | EVP & Group Pres, Cardiology | 100,000 | $62.31 | $65.4B | -59.79% | +4.34% | $6.2M | +0.00% | 10b5-1 | Sell Now |
| Sep 2, 2025 | Sell | BSX | Joseph Michael Fitzgerald | EVP & Group Pres, Cardiology | 100,000 | $65.79 | $65.4B | -59.79% | +4.34% | $6.6M | +0.00% | 10b5-1 | Sell Now |
| Aug 2, 2025 | Sell | BSX | Jonathan Monson | EVP and CFO | 528 | $105.41 | $65.4B | -59.79% | +4.34% | $55.7K | -1.47% | — | Sell Now |
| Aug 1, 2025 | Sell | BSX | Arthur C Butcher | EVP& Grp Pres, MedSurg & APAC | 34,626 | $64.72 | $65.4B | -59.79% | +4.34% | $2.2M | +0.00% | 10b5-1 | Sell Now |
| Aug 1, 2025 | Sell | BSX | Joseph Michael Fitzgerald | EVP & Group Pres, Cardiology | 100,000 | $65.39 | $65.4B | -59.79% | +4.34% | $6.5M | +0.00% | 10b5-1 | Sell Now |
| Jul 1, 2025 | Sell | BSX | Vance R Brown | SVP, GC and Corp. Secretary | 1,952 | $104.78 | $65.4B | -59.79% | +4.34% | $204.5K | -5.51% | — | Sell Now |
| Jul 1, 2025 | Sell | BSX | Joseph Michael Fitzgerald | EVP & Group Pres, Cardiology | 100,000 | $66.56 | $65.4B | -59.79% | +4.34% | $6.7M | +0.00% | 10b5-1 | Sell Now |
| Jun 4, 2025 | Sell | BSX | Joseph Michael Fitzgerald | EVP & Group Pres, Cardiology | 112,744 | $64.52 | $65.4B | -59.79% | +4.34% | $7.3M | +0.00% | 10b5-1 | Sell Now |
| Jun 2, 2025 | Sell | BSX | Michael F Mahoney | Chairman, President & CEO | 270,062 | $71.22 | $65.4B | -59.79% | +4.34% | $19.2M | -0.91% | 10b5-1 | Sell Now |
| May 21, 2025 | Sell | BSX | Vance R Brown | SVP, GC and Corp. Secretary | 4,826 | $106.42 | $65.4B | -59.79% | +4.34% | $513.6K | -13.33% | 10b5-1 | Sell Now |
| May 2, 2025 | Sell | BSX | Arthur C Butcher | EVP& Grp Pres, MedSurg & APAC | 1,017 | $104.93 | $65.4B | -59.79% | +4.34% | $106.7K | -3.85% | — | Sell Now |
| May 2, 2025 | Sell | BSX | John Bradley Sorenson | EVP, Global Operations | 6,490 | $104.66 | $65.4B | -59.79% | +4.34% | $679.2K | -12.32% | 10b5-1 | Sell Now |
| May 1, 2025 | Sell | BSX | Arthur C Butcher | EVP& Grp Pres, MedSurg & APAC | 34,628 | $63.43 | $65.4B | -59.79% | +4.34% | $2.2M | +0.00% | 10b5-1 | Sell Now |
| May 1, 2025 | Sell | BSX | Michael F Mahoney | Chairman, President & CEO | 270,062 | $70.48 | $65.4B | -59.79% | +4.34% | $19.0M | -0.86% | 10b5-1 | Sell Now |
| Apr 21, 2025 | Sell | BSX | Vance R Brown | SVP, GC and Corp. Secretary | 4,826 | $95.09 | $65.4B | -59.79% | +4.34% | $458.9K | -11.77% | 10b5-1 | Sell Now |
| Apr 1, 2025 | Sell | BSX | Michael F Mahoney | Chairman, President & CEO | 270,060 | $68.98 | $65.4B | -59.79% | +4.34% | $18.6M | -1.07% | 10b5-1 | Sell Now |
| Mar 21, 2025 | Sell | BSX | Vance R Brown | SVP, GC and Corp. Secretary | 4,826 | $100.85 | $65.4B | -59.79% | +4.34% | $486.7K | -10.53% | 10b5-1 | Sell Now |
| Mar 3, 2025 | Sell | BSX | Emily Woodworth | SVP, Global Controller and CAO | 13,580 | $75.40 | $65.4B | -59.79% | +4.34% | $1.0M | -12.48% | 10b5-1 | Sell Now |
| Feb 28, 2025 | Sell | BSX | Emily Woodworth | SVP, Global Controller and CAO | 17,460 | $76.81 | $65.4B | -59.79% | +4.34% | $1.3M | -14.54% | 10b5-1 | Sell Now |
| Feb 24, 2025 | Sell | BSX | Joseph Michael Fitzgerald | EVP & Group Pres, Cardiology | 2,380 | $104.39 | $65.4B | -59.79% | +4.34% | $248.4K | -0.47% | — | Sell Now |
| Feb 24, 2025 | Sell | BSX | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | 7,363 | $104.16 | $65.4B | -59.79% | +4.34% | $766.9K | -11.96% | 10b5-1 | Sell Now |
| Feb 21, 2025 | Sell | BSX | Vance R Brown | SVP, GC and Corp. Secretary | 4,826 | $104.64 | $65.4B | -59.79% | +4.34% | $505.0K | -9.52% | 10b5-1 | Sell Now |
| Feb 20, 2025 | Sell | BSX | Joseph Michael Fitzgerald | EVP & Group Pres, Cardiology | 1,000 | $105.36 | $65.4B | -59.79% | +4.34% | $105.4K | -0.55% | — | Sell Now |
| Feb 19, 2025 | Sell | BSX | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | 1,510 | $105.35 | $65.4B | -59.79% | +4.34% | $159.1K | -4.36% | 10b5-1 | Sell Now |
| Feb 18, 2025 | Sell | BSX | John Bradley Sorenson | EVP, Global Operations | 5,960 | $104.84 | $65.4B | -59.79% | +4.34% | $624.9K | -11.63% | 10b5-1 | Sell Now |
| Feb 18, 2025 | Sell | BSX | Daniel J. Brennan | EVP and CFO | 145,386 | $72.01 | $65.4B | -59.79% | +4.34% | $10.5M | -1.26% | 10b5-1 | Sell Now |
| Feb 14, 2025 | Sell | BSX | Emily Woodworth | SVP, Global Controller and CAO | 869 | $106.11 | $65.4B | -59.79% | +4.34% | $92.2K | -3.34% | — | Sell Now |
| Feb 14, 2025 | Sell | BSX | Miriam O'Sullivan | SVP, Chief HR Officer | 1,019 | $106.11 | $65.4B | -59.79% | +4.34% | $108.1K | -1.69% | — | Sell Now |
| Feb 14, 2025 | Sell | BSX | Vance R Brown | SVP, GC and Corp. Secretary | 2,269 | $106.11 | $65.4B | -59.79% | +4.34% | $240.8K | -1.31% | — | Sell Now |
| Feb 14, 2025 | Sell | BSX | John Bradley Sorenson | EVP, Global Operations | 3,431 | $106.18 | $65.4B | -59.79% | +4.34% | $364.3K | -2.65% | 10b5-1 | Sell Now |
| Feb 14, 2025 | Sell | BSX | Arthur C Butcher | EVP& Grp Pres, MedSurg & APAC | 4,080 | $106.11 | $65.4B | -59.79% | +4.34% | $432.9K | -3.80% | — | Sell Now |
| Feb 14, 2025 | Sell | BSX | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | 4,142 | $106.11 | $65.4B | -59.79% | +4.34% | $439.5K | -3.19% | — | Sell Now |
| Feb 14, 2025 | Sell | BSX | Joseph Michael Fitzgerald | EVP & Group Pres, Cardiology | 5,853 | $106.11 | $65.4B | -59.79% | +4.34% | $621.1K | -0.98% | — | Sell Now |
| Feb 14, 2025 | Sell | BSX | Daniel J. Brennan | EVP and CFO | 6,379 | $106.11 | $65.4B | -59.79% | +4.34% | $676.9K | -0.80% | — | Sell Now |
| Feb 14, 2025 | Sell | BSX | Michael F Mahoney | Chairman, President & CEO | 24,720 | $106.11 | $65.4B | -59.79% | +4.34% | $2.6M | -0.48% | — | Sell Now |
| Feb 12, 2025 | Sell | BSX | Emily Woodworth | SVP, Global Controller and CAO | 231 | $105.77 | $65.4B | -59.79% | +4.34% | $24.4K | -4.73% | — | Sell Now |
| Feb 12, 2025 | Sell | BSX | Miriam O'Sullivan | SVP, Chief HR Officer | 361 | $105.77 | $65.4B | -59.79% | +4.34% | $38.2K | -2.06% | — | Sell Now |
| Feb 12, 2025 | Sell | BSX | Vance R Brown | SVP, GC and Corp. Secretary | 424 | $105.77 | $65.4B | -59.79% | +4.34% | $44.8K | -0.80% | — | Sell Now |
| Feb 12, 2025 | Sell | BSX | John Bradley Sorenson | EVP, Global Operations | 530 | $105.77 | $65.4B | -59.79% | +4.34% | $56.1K | -1.70% | — | Sell Now |
| Feb 12, 2025 | Sell | BSX | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | 868 | $105.77 | $65.4B | -59.79% | +4.34% | $91.8K | -2.35% | — | Sell Now |
| Feb 12, 2025 | Sell | BSX | Arthur C Butcher | EVP& Grp Pres, MedSurg & APAC | 950 | $105.77 | $65.4B | -59.79% | +4.34% | $100.5K | -3.55% | — | Sell Now |
| Feb 12, 2025 | Sell | BSX | Joseph Michael Fitzgerald | EVP & Group Pres, Cardiology | 1,579 | $105.77 | $65.4B | -59.79% | +4.34% | $167.0K | -0.85% | — | Sell Now |
| Feb 12, 2025 | Sell | BSX | Daniel J. Brennan | EVP and CFO | 1,767 | $105.77 | $65.4B | -59.79% | +4.34% | $186.9K | -0.69% | — | Sell Now |
| Feb 12, 2025 | Sell | BSX | Michael F Mahoney | Chairman, President & CEO | 6,626 | $105.77 | $65.4B | -59.79% | +4.34% | $700.8K | -0.40% | — | Sell Now |
| Feb 11, 2025 | Sell | BSX | Vance R Brown | SVP, GC and Corp. Secretary | 6,350 | $105.98 | $65.4B | -59.79% | +4.34% | $673.0K | -11.85% | — | Sell Now |
| Feb 11, 2025 | Sell | BSX | Arthur C Butcher | EVP& Grp Pres, MedSurg & APAC | 9,847 | $105.98 | $65.4B | -59.79% | +4.34% | $1.0M | -38.07% | — | Sell Now |
| Feb 11, 2025 | Sell | BSX | John Bradley Sorenson | EVP, Global Operations | 12,338 | $86.99 | $65.4B | -59.79% | +4.34% | $1.1M | -12.32% | 10b5-1 | Sell Now |
| Feb 11, 2025 | Sell | BSX | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | 23,760 | $105.48 | $65.4B | -59.79% | +4.34% | $2.5M | -25.36% | 10b5-1 | Sell Now |
| Feb 11, 2025 | Sell | BSX | Daniel J. Brennan | EVP and CFO | 46,588 | $76.65 | $65.4B | -59.79% | +4.34% | $3.6M | -2.17% | 10b5-1 | Sell Now |
| Feb 11, 2025 | Sell | BSX | Michael F Mahoney | Chairman, President & CEO | 62,915 | $105.98 | $65.4B | -59.79% | +4.34% | $6.7M | -3.74% | — | Sell Now |
| Feb 7, 2025 | Sell | BSX | John Bradley Sorenson | EVP, Global Operations | 6,528 | $104.97 | $65.4B | -59.79% | +4.34% | $685.2K | -19.80% | 10b5-1 | Sell Now |
| Feb 3, 2025 | Sell | BSX | Arthur C Butcher | EVP& Grp Pres, MedSurg & APAC | 34,626 | $63.31 | $65.4B | -59.79% | +4.34% | $2.2M | +0.00% | 10b5-1 | Sell Now |
| Jan 1, 2025 | Sell | BSX | Vance R Brown | SVP, GC and Corp. Secretary | 1,991 | $89.32 | $65.4B | -59.79% | +4.34% | $177.8K | -4.87% | — | Sell Now |
| Jan 1, 2025 | Sell | BSX | Arthur C Butcher | EVP& Grp Pres, MedSurg & APAC | 4,416 | $89.32 | $65.4B | -59.79% | +4.34% | $394.4K | -44.53% | — | Sell Now |
| Jan 1, 2025 | Sell | BSX | Joseph Michael Fitzgerald | EVP & Group Pres, Cardiology | 6,425 | $89.32 | $65.4B | -59.79% | +4.34% | $573.9K | -3.97% | — | Sell Now |
| Jan 1, 2025 | Sell | BSX | John Bradley Sorenson | EVP, Global Operations | 8,588 | $89.80 | $65.4B | -59.79% | +4.34% | $771.2K | -7.38% | 10b5-1 | Sell Now |
| Jan 1, 2025 | Sell | BSX | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | 10,430 | $89.69 | $65.4B | -59.79% | +4.34% | $935.4K | -14.00% | 10b5-1 | Sell Now |
| Jan 1, 2025 | Sell | BSX | Daniel J. Brennan | EVP and CFO | 14,901 | $89.67 | $65.4B | -59.79% | +4.34% | $1.3M | -3.15% | 10b5-1 | Sell Now |
| Jan 1, 2025 | Sell | BSX | Michael F Mahoney | Chairman, President & CEO | 25,656 | $89.32 | $65.4B | -59.79% | +4.34% | $2.3M | -1.63% | — | Sell Now |
| Dec 3, 2024 | Sell | BSX | Joseph Michael Fitzgerald | EVP & Group Pres, Cardiology | 14,517 | $105.90 | $65.4B | -59.79% | +4.34% | $1.5M | -2.98% | — | Sell Now |
| Dec 2, 2024 | Sell | BSX | Wendy Carruthers | EVP, Human Resources | 11,246 | $63.69 | $65.4B | -59.79% | +4.34% | $716.2K | -2.33% | 10b5-1 | Sell Now |
| Nov 27, 2024 | Sell | BSX | Emily Woodworth | SVP, Global Controller and CAO | 1,336 | $90.65 | $65.4B | -59.79% | +4.34% | $121.1K | -31.12% | — | Sell Now |
| Nov 26, 2024 | Sell | BSX | Michael F Mahoney | Chairman, President & CEO | 7,800 | $90.21 | $65.4B | -59.79% | +4.34% | $703.6K | -3.73% | — | Sell Now |
| Nov 25, 2024 | Sell | BSX | Joseph Michael Fitzgerald | EVP & Group Pres, Cardiology | 12,349 | $89.25 | $65.4B | -59.79% | +4.34% | $1.1M | -3.86% | — | Sell Now |
| Nov 25, 2024 | Sell | BSX | Arthur C Butcher | EVP& Grp Pres, MedSurg & APAC | 18,196 | $73.66 | $65.4B | -59.79% | +4.34% | $1.3M | -17.38% | 10b5-1 | Sell Now |
| Nov 12, 2024 | Sell | BSX | John Bradley Sorenson | EVP, Global Operations | 2,610 | $88.72 | $65.4B | -59.79% | +4.34% | $231.6K | -6.57% | — | Sell Now |
| Nov 8, 2024 | Sell | BSX | John Bradley Sorenson | EVP, Global Operations | 47,942 | $64.80 | $65.4B | -59.79% | +4.34% | $3.1M | -10.73% | 10b5-1 | Sell Now |
| Nov 5, 2024 | Sell | BSX | Michael F Mahoney | Chairman, President & CEO | 274,665 | $57.06 | $65.4B | -59.79% | +4.34% | $15.7M | -0.76% | 10b5-1 | Sell Now |
| Nov 1, 2024 | Sell | BSX | Wendy Carruthers | EVP, Human Resources | 11,246 | $59.68 | $65.4B | -59.79% | +4.34% | $671.2K | -2.11% | 10b5-1 | Sell Now |
| Oct 7, 2024 | Sell | BSX | Joseph Michael Fitzgerald | EVP & Group Pres, Cardiology | 249,166 | $55.08 | $65.4B | -59.79% | +4.34% | $13.7M | -2.25% | 10b5-1 | Sell Now |
| Oct 7, 2024 | Sell | BSX | Michael F Mahoney | Chairman, President & CEO | 274,663 | $56.99 | $65.4B | -59.79% | +4.34% | $15.7M | -0.73% | 10b5-1 | Sell Now |
| Oct 1, 2024 | Sell | BSX | Wendy Carruthers | EVP, Human Resources | 11,246 | $59.39 | $65.4B | -59.79% | +4.34% | $667.9K | -1.92% | 10b5-1 | Sell Now |
| Sep 5, 2024 | Sell | BSX | Michael F Mahoney | Chairman, President & CEO | 274,663 | $54.94 | $65.4B | -59.79% | +4.34% | $15.1M | -0.91% | 10b5-1 | Sell Now |
| Sep 3, 2024 | Sell | BSX | Wendy Carruthers | EVP, Human Resources | 11,246 | $58.05 | $65.4B | -59.79% | +4.34% | $652.8K | -1.77% | 10b5-1 | Sell Now |
| Aug 30, 2024 | Buy | BSX | Michael F Mahoney | Chairman, President & CEO | 385,523 | $81.79 | $65.4B | -59.79% | +4.34% | $31.5M | +3.88% | — | Sell Now |
| Aug 28, 2024 | Sell | BSX | Joseph Michael Fitzgerald | EVP & Group Pres, Cardiology | 14,132 | $80.00 | $65.4B | -59.79% | +4.34% | $1.1M | -7.42% | 10b5-1 | Sell Now |
| Aug 26, 2024 | Sell | BSX | Arthur C Butcher | EVP& Grp Pres, MedSurg & APAC | 18,197 | $65.95 | $65.4B | -59.79% | +4.34% | $1.2M | -10.90% | 10b5-1 | Sell Now |
| Aug 1, 2024 | Sell | BSX | Wendy Carruthers | EVP, Human Resources | 11,246 | $53.34 | $65.4B | -59.79% | +4.34% | $599.9K | -1.64% | 10b5-1 | Sell Now |
| Jul 1, 2024 | Sell | BSX | Vance R Brown | SVP, GC and Corp. Secretary | 1,952 | $76.41 | $65.4B | -59.79% | +4.34% | $149.2K | -4.83% | — | Sell Now |
| Jul 1, 2024 | Sell | BSX | Wendy Carruthers | EVP, Human Resources | 11,246 | $55.32 | $65.4B | -59.79% | +4.34% | $622.1K | -1.52% | 10b5-1 | Sell Now |
| Jun 3, 2024 | Sell | BSX | Wendy Carruthers | EVP, Human Resources | 11,246 | $54.09 | $65.4B | -59.79% | +4.34% | $608.3K | -1.42% | 10b5-1 | Sell Now |
| May 29, 2024 | Sell | BSX | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | 97,528 | $55.10 | $65.4B | -59.79% | +4.34% | $5.4M | -20.06% | 10b5-1 | Sell Now |
| May 28, 2024 | Sell | BSX | Arthur C Butcher | EVP& Grp Pres, MedSurg & APAC | 18,197 | $62.93 | $65.4B | -59.79% | +4.34% | $1.1M | -8.02% | 10b5-1 | Sell Now |
| May 22, 2024 | Sell | BSX | Daniel J. Brennan | EVP and CFO | 176,529 | $55.77 | $65.4B | -59.79% | +4.34% | $9.8M | -2.47% | 10b5-1 | Sell Now |
| May 21, 2024 | Sell | BSX | Vance R Brown | SVP, GC and Corp. Secretary | 66,086 | $50.75 | $65.4B | -59.79% | +4.34% | $3.4M | +0.00% | 10b5-1 | Sell Now |
| May 13, 2024 | Sell | BSX | Joseph Michael Fitzgerald | EVP & Group Pres, Cardiology | 2,380 | $72.81 | $65.4B | -59.79% | +4.34% | $173.3K | -1.23% | — | Sell Now |
| May 10, 2024 | Sell | BSX | Eric Francis Yves Thepaut | EVP & Pres, Eur, Mid-East, Afr | 25,862 | $45.23 | $65.4B | -59.79% | +4.34% | $1.2M | +0.00% | — | Sell Now |
| May 2, 2024 | Sell | BSX | Arthur C Butcher | EVP& Grp Pres, MedSurg & APAC | 1,017 | $72.03 | $65.4B | -59.79% | +4.34% | $73.3K | -2.89% | — | Sell Now |
| May 2, 2024 | Sell | BSX | John Bradley Sorenson | EVP, Global Operations | 1,917 | $72.03 | $65.4B | -59.79% | +4.34% | $138.1K | -3.03% | — | Sell Now |
| May 1, 2024 | Sell | BSX | Wendy Carruthers | EVP, Human Resources | 11,246 | $51.70 | $65.4B | -59.79% | +4.34% | $581.4K | -1.34% | 10b5-1 | Sell Now |
| May 1, 2024 | Sell | BSX | John Bradley Sorenson | EVP, Global Operations | 35,174 | $44.38 | $65.4B | -59.79% | +4.34% | $1.6M | +0.00% | 10b5-1 | Sell Now |
| Apr 1, 2024 | Sell | BSX | Wendy Carruthers | EVP, Human Resources | 11,246 | $49.80 | $65.4B | -59.79% | +4.34% | $560.1K | -1.26% | 10b5-1 | Sell Now |
| Apr 1, 2024 | Sell | BSX | John Bradley Sorenson | EVP, Global Operations | 32,702 | $42.80 | $65.4B | -59.79% | +4.34% | $1.4M | +0.00% | 10b5-1 | Sell Now |
| Mar 18, 2024 | Sell | BSX | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | 14,506 | $66.45 | $65.4B | -59.79% | +4.34% | $963.9K | -19.98% | 10b5-1 | Sell Now |
| Mar 1, 2024 | Sell | BSX | Wendy Carruthers | EVP, Human Resources | 11,246 | $48.52 | $65.4B | -59.79% | +4.34% | $545.6K | -1.19% | 10b5-1 | Sell Now |
| Feb 26, 2024 | Sell | BSX | Arthur C Butcher | EVP& Grp Pres, MedSurg & APAC | 13,520 | $52.93 | $65.4B | -59.79% | +4.34% | $715.6K | -3.71% | 10b5-1 | Sell Now |
| Feb 23, 2024 | Sell | BSX | Wendy Carruthers | EVP, Human Resources | 11,246 | $48.85 | $65.4B | -59.79% | +4.34% | $549.4K | -1.13% | 10b5-1 | Sell Now |
| Feb 21, 2024 | Sell | BSX | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | 4,960 | $66.35 | $65.4B | -59.79% | +4.34% | $329.1K | -6.39% | 10b5-1 | Sell Now |
| Feb 18, 2024 | Sell | BSX | Eric Francis Yves Thepaut | EVP & Pres, Eur, Mid-East, Afr | 1,160 | $65.82 | $65.4B | -59.79% | +4.34% | $76.4K | -3.72% | — | Sell Now |
| Feb 16, 2024 | Sell | BSX | Vance R Brown | SVP, GC and Corp. Secretary | 1,052 | $65.82 | $65.4B | -59.79% | +4.34% | $69.2K | -1.04% | — | Sell Now |
| Feb 16, 2024 | Sell | BSX | Jonathan Monson | SVP, Global Controller and CAO | 1,089 | $65.82 | $65.4B | -59.79% | +4.34% | $71.7K | -0.93% | — | Sell Now |
| Feb 16, 2024 | Sell | BSX | John Bradley Sorenson | EVP, Global Operations | 1,807 | $65.82 | $65.4B | -59.79% | +4.34% | $118.9K | -1.16% | — | Sell Now |
| Feb 16, 2024 | Sell | BSX | Wendy Carruthers | EVP, Human Resources | 5,780 | $31.09 | $65.4B | -59.79% | +4.34% | $179.7K | -2.27% | — | Sell Now |
| Feb 16, 2024 | Sell | BSX | Eric Francis Yves Thepaut | EVP & Pres, Eur, Mid-East, Afr | 2,759 | $65.82 | $65.4B | -59.79% | +4.34% | $181.6K | -4.11% | — | Sell Now |
| Feb 16, 2024 | Sell | BSX | Arthur C Butcher | EVP& Grp Pres, MedSurg & APAC | 3,439 | $65.82 | $65.4B | -59.79% | +4.34% | $226.4K | -3.14% | — | Sell Now |
| Feb 16, 2024 | Sell | BSX | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | 4,160 | $65.82 | $65.4B | -59.79% | +4.34% | $273.8K | -1.72% | — | Sell Now |
| Feb 16, 2024 | Sell | BSX | Joseph Michael Fitzgerald | EVP & Group Pres, Cardiology | 5,692 | $65.82 | $65.4B | -59.79% | +4.34% | $374.6K | -0.96% | — | Sell Now |
| Feb 16, 2024 | Sell | BSX | Daniel J. Brennan | EVP and CFO | 32,883 | $43.92 | $65.4B | -59.79% | +4.34% | $1.4M | -0.40% | — | Sell Now |
| Feb 16, 2024 | Sell | BSX | Michael F Mahoney | Chairman, President & CEO | 22,578 | $65.82 | $65.4B | -59.79% | +4.34% | $1.5M | -0.45% | — | Sell Now |
| Feb 14, 2024 | Sell | BSX | Jonathan Monson | SVP, Global Controller and CAO | 488 | $65.95 | $65.4B | -59.79% | +4.34% | $32.2K | -1.22% | — | Sell Now |
| Feb 14, 2024 | Sell | BSX | Vance R Brown | SVP, GC and Corp. Secretary | 629 | $65.95 | $65.4B | -59.79% | +4.34% | $41.5K | -1.75% | — | Sell Now |
| Feb 14, 2024 | Sell | BSX | Wendy Carruthers | EVP, Human Resources | 939 | $65.95 | $65.4B | -59.79% | +4.34% | $61.9K | -1.42% | — | Sell Now |
| Feb 14, 2024 | Sell | BSX | John Bradley Sorenson | EVP, Global Operations | 965 | $65.95 | $65.4B | -59.79% | +4.34% | $63.6K | -1.73% | — | Sell Now |
| Feb 14, 2024 | Sell | BSX | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | 1,266 | $65.95 | $65.4B | -59.79% | +4.34% | $83.5K | -1.54% | — | Sell Now |
| Feb 14, 2024 | Sell | BSX | Eric Francis Yves Thepaut | EVP & Pres, Eur, Mid-East, Afr | 1,378 | $65.95 | $65.4B | -59.79% | +4.34% | $90.9K | -3.86% | — | Sell Now |
| Feb 14, 2024 | Sell | BSX | Arthur C Butcher | EVP& Grp Pres, MedSurg & APAC | 1,408 | $65.95 | $65.4B | -59.79% | +4.34% | $92.9K | -3.46% | — | Sell Now |
| Feb 14, 2024 | Sell | BSX | Daniel J. Brennan | EVP and CFO | 1,935 | $65.95 | $65.4B | -59.79% | +4.34% | $127.6K | -0.69% | — | Sell Now |
| Feb 14, 2024 | Sell | BSX | Joseph Michael Fitzgerald | EVP & Group Pres, Cardiology | 1,990 | $65.95 | $65.4B | -59.79% | +4.34% | $131.2K | -0.99% | — | Sell Now |
| Feb 14, 2024 | Sell | BSX | Michael F Mahoney | Chairman, President & CEO | 7,328 | $65.95 | $65.4B | -59.79% | +4.34% | $483.3K | -0.43% | — | Sell Now |
| Feb 12, 2024 | Sell | BSX | Joseph Michael Fitzgerald | EVP & Group Pres, Cardiology | 6,550 | $64.99 | $65.4B | -59.79% | +4.34% | $425.7K | -2.22% | — | Sell Now |
| Feb 6, 2024 | Sell | BSX | John Bradley Sorenson | EVP, Global Operations | 5,472 | $64.79 | $65.4B | -59.79% | +4.34% | $354.5K | -10.36% | — | Sell Now |
| Feb 6, 2024 | Sell | BSX | Wendy Carruthers | EVP, Human Resources | 7,983 | $64.79 | $65.4B | -59.79% | +4.34% | $517.2K | -12.16% | — | Sell Now |
| Feb 6, 2024 | Sell | BSX | Arthur C Butcher | EVP& Grp Pres, MedSurg & APAC | 9,722 | $64.79 | $65.4B | -59.79% | +4.34% | $629.9K | -25.77% | — | Sell Now |
| Feb 6, 2024 | Sell | BSX | Eric Francis Yves Thepaut | EVP & Pres, Eur, Mid-East, Afr | 11,579 | $64.79 | $65.4B | -59.79% | +4.34% | $750.2K | -30.65% | — | Sell Now |
| Feb 6, 2024 | Sell | BSX | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | 12,160 | $64.79 | $65.4B | -59.79% | +4.34% | $787.8K | -14.61% | — | Sell Now |
| Feb 6, 2024 | Sell | BSX | Daniel J. Brennan | EVP and CFO | 16,262 | $64.79 | $65.4B | -59.79% | +4.34% | $1.1M | -5.84% | — | Sell Now |
| Feb 6, 2024 | Sell | BSX | Joseph Michael Fitzgerald | EVP & Group Pres, Cardiology | 16,450 | $64.79 | $65.4B | -59.79% | +4.34% | $1.1M | -7.95% | — | Sell Now |
| Feb 6, 2024 | Sell | BSX | Michael F Mahoney | Chairman, President & CEO | 65,047 | $64.79 | $65.4B | -59.79% | +4.34% | $4.2M | -3.82% | — | Sell Now |
| Jan 12, 2024 | Sell | BSX | Joseph Michael Fitzgerald | EVP & Group Pres, Cardiology | 11,660 | $60.00 | $65.4B | -59.79% | +4.34% | $699.6K | -6.30% | 10b5-1 | Sell Now |
| Jan 9, 2024 | Sell | BSX | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | 30,344 | $37.78 | $65.4B | -59.79% | +4.34% | $1.1M | +0.00% | 10b5-1 | Sell Now |
| Jan 4, 2024 | Sell | BSX | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | 30,000 | $37.36 | $65.4B | -59.79% | +4.34% | $1.1M | +0.00% | 10b5-1 | Sell Now |
| Jan 3, 2024 | Sell | BSX | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | 11,931 | $57.82 | $65.4B | -59.79% | +4.34% | $689.9K | -17.41% | 10b5-1 | Sell Now |
| Jan 1, 2024 | Sell | BSX | John Bradley Sorenson | EVP, Global Operations | 3,729 | $57.81 | $65.4B | -59.79% | +4.34% | $215.6K | -8.37% | — | Sell Now |
| Jan 1, 2024 | Sell | BSX | Wendy Carruthers | EVP, Human Resources | 5,380 | $57.81 | $65.4B | -59.79% | +4.34% | $311.0K | -10.14% | — | Sell Now |
| Jan 1, 2024 | Sell | BSX | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | 5,508 | $57.81 | $65.4B | -59.79% | +4.34% | $318.4K | -7.44% | — | Sell Now |
| Jan 1, 2024 | Sell | BSX | Arthur C Butcher | EVP& Grp Pres, MedSurg & APAC | 6,733 | $57.81 | $65.4B | -59.79% | +4.34% | $389.2K | -30.89% | — | Sell Now |
| Jan 1, 2024 | Sell | BSX | Eric Francis Yves Thepaut | EVP & Pres, Eur, Mid-East, Afr | 7,573 | $57.81 | $65.4B | -59.79% | +4.34% | $437.8K | -29.87% | — | Sell Now |
| Jan 1, 2024 | Sell | BSX | Daniel J. Brennan | EVP and CFO | 8,199 | $57.81 | $65.4B | -59.79% | +4.34% | $474.0K | -3.28% | — | Sell Now |
| Jan 1, 2024 | Sell | BSX | Michael F Mahoney | Chairman, President & CEO | 40,104 | $57.81 | $65.4B | -59.79% | +4.34% | $2.3M | -2.51% | — | Sell Now |
| Dec 29, 2023 | Sell | BSX | Joseph Michael Fitzgerald | EVP & Group Pres, Cardiology | 151,037 | $41.65 | $65.4B | -59.79% | +4.34% | $6.3M | -5.33% | 10b5-1 | Sell Now |
| Dec 15, 2023 | Sell | BSX | Wendy Carruthers | EVP, Human Resources | 18,081 | $41.15 | $65.4B | -59.79% | +4.34% | $744.0K | -3.52% | 10b5-1 | Sell Now |
| Dec 6, 2023 | Sell | BSX | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | 353 | $55.03 | $65.4B | -59.79% | +4.34% | $19.4K | -0.62% | 10b5-1 | Sell Now |
| Dec 3, 2023 | Sell | BSX | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | 296 | $56.14 | $65.4B | -59.79% | +4.34% | $16.6K | -0.52% | — | Sell Now |
| Nov 20, 2023 | Sell | BSX | Arthur C Butcher | EVP& Grp Pres, MedSurg & APAC | 12,137 | $42.36 | $65.4B | -59.79% | +4.34% | $514.1K | -12.73% | 10b5-1 | Sell Now |
| Nov 15, 2023 | Sell | BSX | Wendy Carruthers | EVP, Human Resources | 18,079 | $40.22 | $65.4B | -59.79% | +4.34% | $727.2K | -3.07% | 10b5-1 | Sell Now |
| Nov 8, 2023 | Sell | BSX | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | 4,000 | $52.11 | $65.4B | -59.79% | +4.34% | $208.4K | -6.60% | — | Sell Now |
| Nov 6, 2023 | Sell | BSX | Michael F Mahoney | Chairman, President & CEO | 226,712 | $33.59 | $65.4B | -59.79% | +4.34% | $7.6M | +0.00% | 10b5-1 | Sell Now |
| Oct 16, 2023 | Sell | BSX | Wendy Carruthers | EVP, Human Resources | 18,079 | $37.39 | $65.4B | -59.79% | +4.34% | $676.0K | -2.72% | 10b5-1 | Sell Now |
| Oct 9, 2023 | Sell | BSX | Michael F Mahoney | Chairman, President & CEO | 226,710 | $33.38 | $65.4B | -59.79% | +4.34% | $7.6M | +0.00% | 10b5-1 | Sell Now |
| Sep 20, 2023 | Sell | BSX | Joseph Michael Fitzgerald | EVP & Group Pres, Cardiology | 15,867 | $55.00 | $65.4B | -59.79% | +4.34% | $872.7K | -7.42% | 10b5-1 | Sell Now |
| Sep 15, 2023 | Sell | BSX | Wendy Carruthers | EVP, Human Resources | 18,079 | $40.08 | $65.4B | -59.79% | +4.34% | $724.6K | -2.44% | 10b5-1 | Sell Now |
| Sep 12, 2023 | Sell | BSX | Michael F Mahoney | Chairman, President & CEO | 226,710 | $34.29 | $65.4B | -59.79% | +4.34% | $7.8M | +0.00% | 10b5-1 | Sell Now |
| Aug 30, 2023 | Sell | BSX | Michael F Mahoney | Chairman, President & CEO | 460,763 | $54.27 | $65.4B | -59.79% | +4.34% | $25.0M | -8.67% | — | Sell Now |
| Aug 28, 2023 | Sell | BSX | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | 18,628 | $53.48 | $65.4B | -59.79% | +4.34% | $996.2K | -12.89% | 10b5-1 | Sell Now |
| Aug 25, 2023 | Sell | BSX | Vance R Brown | SVP, GC and Corp. Secretary | 15,750 | $50.52 | $65.4B | -59.79% | +4.34% | $795.8K | -35.53% | 10b5-1 | Sell Now |
| Aug 21, 2023 | Sell | BSX | Arthur C Butcher | EVP& Grp Pres, MedSurg & APAC | 6,600 | $50.40 | $65.4B | -59.79% | +4.34% | $332.7K | -36.67% | 10b5-1 | Sell Now |
| Aug 15, 2023 | Sell | BSX | Wendy Carruthers | EVP, Human Resources | 18,079 | $38.37 | $65.4B | -59.79% | +4.34% | $693.6K | -2.21% | 10b5-1 | Sell Now |